SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-007230
Filing Date
2012-02-02
Accepted
2012-02-02 21:55:47
Documents
1
Period of Report
2012-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6033
  Complete submission text file 0001209191-12-007230.txt   8650
Mailing Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Aisling Capital II LP (Reporting) CIK: 0001350778 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 12567740

Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10106 (212) 651-6380
AISLING CAPITAL PARTNERS LLC (Reporting) CIK: 0001376171 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 12567739

Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10106 (212) 651-6380
AISLING CAPITAL PARTNERS, LP (Reporting) CIK: 0001376172 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 12567738

Mailing Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149
Business Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149 919-313-6617
Cempra Holdings, LLC (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations